Kraus, M R <br/><br/>
Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Jun 2002 
 - 1091-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.2002.01265.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antiviral Agents--adverse effects<br/>Depressive Disorder--chemically induced<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--adverse effects<br/>Male<br/>Middle Aged<br/>Paroxetine--administration & dosage<br/>Patient Compliance<br/>Psychiatric Status Rating Scales<br/>Selective Serotonin Reuptake Inhibitors--administration & dosage<br/>Severity of Illness Index<br/>Treatment Outcome